Regulatory

Regulatory  ·  Weekly digest May 10 2024
Innovent Receives NMPA Breakthrough Therapy Designation for IBI343 (Anti-Claudin18.2 ADC) as Monotherapy for Advanced Gastric Cancer

Weekly Digest – May 2024 Weekly Digest – May 2024 06 May 2024: Innovent Receives NMPA Breakthrough Therapy Designation for IBI343 (Anti-Claudin18.2 ADC) as Monotherapy for Advanced Gastric Cancer China’s NMPA grants BTD to IBI343 as monotherapy for treating claudin18.2-positive […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly digest May 10 2024
FDA Grants Orphan Drug Designation to 9MW2821 for Esophageal Cancer

Weekly Digest – May 2024 Weekly Digest – May 2024 08 May 2024: FDA Grants Orphan Drug Designation to 9MW2821 for Esophageal Cancer 9MW2821 is the first NECTIN-4–directed ADC developed by a Chinese company, Mabwell Therapeutics to enter clinical study […]

by Sandhya Ramalingam

Continue Reading